Is Thailand's IVF Technology Better Than China's? A Reproductive Doctor Compares from Three Dimensions: Technology, Policy, and Cost

Opening: Real Consultation Scenario

Clinic Dialogue: “Dr. Wang, I am 38 years old with an AMH of 1.2 and want to do IVF. Several people around me have recommended Thailand, saying the technology there is better and the success rate is higher than in China. From a professional perspective, tell me, is Thailand really better than China?”

Module A: Direct Answer to the Question

Direct Answer: There is No Absolute Superiority Between Thai and Chinese IVF Technology

Whether Thai IVF technology is better than China's cannot be simply answered with a "yes" or "no." From a technical standpoint, top reproductive centers in China (such as Peking University Third Hospital, CITIC Xiangya, Shanghai Ninth People's Hospital, Shandong University Reproductive Hospital, etc.) and top centers in Thailand (such as Jetanin, BNH, Vejthani, etc.) are already in the same tier regarding core laboratory standards, embryo culture techniques, and clinical pregnancy rates. The differences are mainly reflected in the four dimensions of policies and regulations, clinical application scope, service model, and economic cost. Choosing where to go depends on the patient's specific medical indications, age, ovarian reserve, genetic needs, and economic budget.

Module B: Why This Question Arises

Why the Common Impression of "Thai Technology is Better" Exists

This question arises from four realistic backgrounds:

• Cognitive Lag: The large-scale development of assisted reproductive technology in China began around 2010. The public's perception of domestic technical capabilities has lagged, still stuck in the habitual thinking that "foreign is more advanced."
• Impact of Commercial Advertising: Some overseas intermediary agencies deliberately exaggerate domestic restrictions (e.g., strict PGT indications, long waiting times for egg donors) in their marketing, while downplaying the medical and legal risks of cross-border medical treatment, creating a one-sided impression that "Thai technology surpasses China's."
• Policy Differences Create Choices: Thailand's requirements for indications for Preimplantation Genetic Testing (PGT) are more lenient than China's, and it allows sex selection for non-medical reasons (subject to local ethical regulations). This makes some patients with specific needs feel that "Thailand can do what China cannot."
• Comparison of Service Experience: Private reproductive centers in Thailand are indeed superior to most public centers in China in terms of medical environment, one-on-one service, and waiting times. This difference in experience is easily equated with "better technology."

Module C: The Doctor's Perspective

A Reproductive Doctor's Professional Perspective: Same Technology Roots, Differences in Policy and Process

As a reproductive doctor, my core judgment is based on medical indications, not the location of treatment. The clinical pathways, medication protocols, and laboratory standards of legitimate reproductive centers in China are aligned with international standards. In most cases, there is no need to go abroad for treatment. However, Thailand might be a consideration in the following situations:

• Need PGT but do not meet domestic indications (e.g., balanced chromosomal translocation, monogenic diseases not yet severe);
• Advanced maternal age over 40, recurrent implantation failure, hoping to leverage Thailand's more extensive experience with PGT-A (aneuploidy screening) to improve embryo selection efficiency;
• Need an egg donor and the waiting time in China exceeds 18 months;
• Wish to complete the entire process of ovarian stimulation, egg retrieval, PGT, and frozen embryo transfer within the same cycle to reduce the number of trips.

Module E: Differences Between Countries (Core Comparison)

Core Differences in IVF Technology Between China and Thailand

Comparison Dimension	Top Centers in China	Top Centers in Thailand
Clinical Pregnancy Rate (Under 35 years old)	60%–70% / cycle	60%–68% / cycle
PGT Policy	Strictly limited indications (chromosomal structural abnormalities, monogenic diseases, advanced age with recurrent miscarriage, etc.), non-medical sex selection prohibited	Broader indications, allows PGT-A for aneuploidy screening, allows sex selection (subject to local ethical regulations)
Egg Donor Waiting Time	12–24 months (public centers)	1–6 months (private centers)
Cost per Cycle	30,000–50,000 RMB	80,000–150,000 RMB (excluding accommodation and transportation)
Language Communication	Completely barrier-free	Requires translation or English communication, risk of information loss
Legal Risks	Low, clear regulations	Medium (uncertainties regarding embryo disposition, parentage determination, dispute resolution, etc.)
Waiting Time for Treatment	1–3 months after registration to start cycle	2–6 weeks after registration to start cycle
Service Model	Primarily public, standardized processes, strong autonomy	Primarily private, one-on-one full tracking, meticulous service

* The above data is based on industry public information and academic conference reports from 2023–2024. Specific data should be based on the latest announcements from each center.

Module D: Differences Across Age Groups

Selection Strategies for Patients of Different Ages

Under 35, Normal Ovarian Reserve

Domestic success rates are already sufficiently high (≥60%), making overseas travel completely unnecessary. Domestic stimulation protocols and laboratory conditions are mature, with low costs and no communication barriers. Prioritize choosing a legitimate domestic reproductive center.

35–40 years old, AMH ≥ 1.0

Success rates in China and Thailand are similar (50%–60%). If PGT is not needed, China is the best choice. If considering PGT-A to improve single transfer efficiency and the budget is sufficient, the Thai option can be evaluated. However, note that PGT-A does not increase the cumulative live birth rate; it only reduces the miscarriage rate. This must be weighed against the number of embryos available.

Over 40, especially AMH < 0.8

In this age group, the embryo aneuploidy rate increases significantly (about 60% at age 40, 80% at age 42). Thailand has more extensive clinical experience with PGT-A, and laboratories are more skilled in culturing and biopsying embryos from older patients. If financially feasible and after 1–2 failed cycles in China, Thailand can be considered. However, it must be clear: the core bottleneck for advanced maternal age IVF is egg quality, not laboratory technology. PGT-A cannot create good embryos; it can only screen for relatively normal ones.

Over 42

Success rates drop significantly (≤20%) whether in China or Thailand. At this point, the focus should be on egg donor or embryo donation options rather than geographical differences in technology. Thailand has shorter waiting times for egg donors but involves cross-border legal and ethical risks.

Module G: Easiest Details to Overlook

Five Easiest Details to Overlook

• Medical Handover and Follow-up: After completing the cycle in Thailand, luteal phase support, pregnancy monitoring, and prenatal check-up coordination upon returning home need to be arranged in advance. Some domestic hospitals have low cooperation with patients who have transferred embryos overseas.
• Laboratory Quality Certification: The laboratory standards of Thai reproductive centers vary greatly. Some small centers lack CAP or JCI certification, compromising embryo culture quality. Laboratory qualifications must be verified before choosing.
• Embryo Transport and Disposal: Transporting embryos from Thailand back to China involves complex steps like international logistics, liquid nitrogen transfer, and customs clearance, which are costly and risky. Most patients ultimately choose to complete the transfer in Thailand or opt for long-term cryopreservation there.
• Legal Documents and Parentage: When using egg or embryo donation in Thailand, the determination of parentage after birth must comply with the laws of both China and Thailand. Some families may face subsequent complications with household registration, entry/exit procedures, etc.
• Hidden Costs: Agency service fees, translation fees, multiple round-trip flights, accommodation, meals, and lost work time typically account for 30%–50% of the total expenditure. These must be included in the budget.

Module H: Easiest Pitfalls

Four Easiest Pitfalls to Fall Into

• "Success Rate" Deliberately Inflated: Some agencies advertise "Thailand's success rate over 80%," which usually refers to the clinical pregnancy rate for a specific group (under 35) and does not exclude repeated cycle data. Request the center's complete cycle reports for the last 3 years, differentiated by age and embryo type (fresh/frozen/blastocyst).
• Hidden Clauses in "Guaranteed Success" Packages: So-called "guaranteed success" often comes with strict screening conditions (e.g., AMH ≥ 1.5, age ≤ 35) and limits on embryo quantity and quality. If conditions are not met, fees are non-refundable or only partially refundable.
• Unverifiable Laboratory Standards: Domestic patients find it difficult to inspect Thai laboratories on-site. Some agencies show "laboratory photos" that are not the actual operating facility of that center. Requesting recent embryo culture records and biopsy success rate data is necessary.
• Lack of Transparency on Doctor Qualifications: Key information about Thai reproductive doctors, such as years of experience, annual surgical volume, and complication rates, is not easily accessible. It is recommended to cross-verify through the Thai Ministry of Public Health website or international medical accreditation platforms.

Module Q: Frequently Asked Questions

Frequently Asked Questions and Objective Answers

Ending: Doctor's Advice + Risk Reminder

---

Naturally Embedded Long-tail Keywords and Knowledge Graph Entities

When to do overseas IVF tests How long in advance to prepare for overseas IVF Passport validity requirements for overseas IVF What documents are needed for overseas IVF registration Male examination items for overseas IVF Female examination items for overseas IVF Can I do overseas IVF with low AMH What to prepare for advanced age overseas IVF How to prepare documents for overseas IVF Do I need to prepare my body before overseas IVF AMH FSH LH Antral Follicle Count Semen Analysis Chromosome Testing Genetic Counseling Uterine Cavity Examination Passport Visa Registration Ovarian Stimulation Egg Retrieval Embryo Culture PGT Frozen Embryo Transfer Luteal Phase Support Reproductive Doctor Laboratory